Cargando…

Three-Month Feeding Integration With Bifidobacterium Strains Prevents Gastrointestinal Symptoms in Healthy Newborns

Infantile functional gastrointestinal disorders are common in the first months of life. Their pathogenesis remains unknown although evidences suggest multiple independent causes, including gut microbiota modifications. Feeding type, influencing the composition of intestinal microbiota, could play a...

Descripción completa

Detalles Bibliográficos
Autores principales: Aloisio, Irene, Prodam, Flavia, Giglione, Enza, Bozzi Cionci, Nicole, Solito, Arianna, Bellone, Simonetta, Baffoni, Loredana, Mogna, Luca, Pane, Marco, Bona, Gianni, Di Gioia, Diana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5980983/
https://www.ncbi.nlm.nih.gov/pubmed/29888226
http://dx.doi.org/10.3389/fnut.2018.00039
_version_ 1783327953812193280
author Aloisio, Irene
Prodam, Flavia
Giglione, Enza
Bozzi Cionci, Nicole
Solito, Arianna
Bellone, Simonetta
Baffoni, Loredana
Mogna, Luca
Pane, Marco
Bona, Gianni
Di Gioia, Diana
author_facet Aloisio, Irene
Prodam, Flavia
Giglione, Enza
Bozzi Cionci, Nicole
Solito, Arianna
Bellone, Simonetta
Baffoni, Loredana
Mogna, Luca
Pane, Marco
Bona, Gianni
Di Gioia, Diana
author_sort Aloisio, Irene
collection PubMed
description Infantile functional gastrointestinal disorders are common in the first months of life. Their pathogenesis remains unknown although evidences suggest multiple independent causes, including gut microbiota modifications. Feeding type, influencing the composition of intestinal microbiota, could play a significant role in the pathogenesis. Previous studies supported probiotic supplementation success against colics, however mainly Lactobacillus spp. were tested. The aim of this study was to evaluate the effectiveness against functional gastrointestinal disorders of a Bifidobacterium breve based probiotic formulation including in the study both breast-fed and bottle-fed subjects. Two hundred and sixty-eight newborns were enrolled within 15 days from birth. One hundred and fifty-five of them effectively entered the study and were randomized in probiotic and placebo group, receiving the formulation for 90 days. The probiotic formulation consists of a 1:1 mixture of 2 strains of B. breve prepared in an oily suspension and administered in a daily dosage of 5 drops containing 10(8) CFU of each strain. Absolute quantification of selected microbial groups in the faeces was performed using qPCR. Anthropometric data, daily diary minutes of crying, number of regurgitations, vomits and evacuations, and colour and consistency of stools were evaluated before and after treatment. The study confirmed the positive role of breast milk in influencing the counts of target microbial groups, in particular the bifidobacteria community. No adverse events upon probiotic administration were reported, suggesting the safety of the product in this regimen. B. breve counts increased significantly in all administered newborns (p < 0.02). The study demonstrates that a 3 months treatment with B. breve strains in healthy breast-fed newborns helps to prevent functional gastrointestinal disorders, in particular reducing 56% of daily vomit frequency (p < 0.03), decreasing 46.5% of daily evacuation over time (p < 0.03), and improving the stool consistency (type 6 at the Bristol Stool chart instead of type 5) in those at term (p < 0.0001). Moreover, a significant reduction (8.65 vs. 7.98 LogCFU/g of feces, p < 0.03) of B. fragilis in the bottle-fed group receiving the probiotic formulation was observed.
format Online
Article
Text
id pubmed-5980983
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-59809832018-06-08 Three-Month Feeding Integration With Bifidobacterium Strains Prevents Gastrointestinal Symptoms in Healthy Newborns Aloisio, Irene Prodam, Flavia Giglione, Enza Bozzi Cionci, Nicole Solito, Arianna Bellone, Simonetta Baffoni, Loredana Mogna, Luca Pane, Marco Bona, Gianni Di Gioia, Diana Front Nutr Nutrition Infantile functional gastrointestinal disorders are common in the first months of life. Their pathogenesis remains unknown although evidences suggest multiple independent causes, including gut microbiota modifications. Feeding type, influencing the composition of intestinal microbiota, could play a significant role in the pathogenesis. Previous studies supported probiotic supplementation success against colics, however mainly Lactobacillus spp. were tested. The aim of this study was to evaluate the effectiveness against functional gastrointestinal disorders of a Bifidobacterium breve based probiotic formulation including in the study both breast-fed and bottle-fed subjects. Two hundred and sixty-eight newborns were enrolled within 15 days from birth. One hundred and fifty-five of them effectively entered the study and were randomized in probiotic and placebo group, receiving the formulation for 90 days. The probiotic formulation consists of a 1:1 mixture of 2 strains of B. breve prepared in an oily suspension and administered in a daily dosage of 5 drops containing 10(8) CFU of each strain. Absolute quantification of selected microbial groups in the faeces was performed using qPCR. Anthropometric data, daily diary minutes of crying, number of regurgitations, vomits and evacuations, and colour and consistency of stools were evaluated before and after treatment. The study confirmed the positive role of breast milk in influencing the counts of target microbial groups, in particular the bifidobacteria community. No adverse events upon probiotic administration were reported, suggesting the safety of the product in this regimen. B. breve counts increased significantly in all administered newborns (p < 0.02). The study demonstrates that a 3 months treatment with B. breve strains in healthy breast-fed newborns helps to prevent functional gastrointestinal disorders, in particular reducing 56% of daily vomit frequency (p < 0.03), decreasing 46.5% of daily evacuation over time (p < 0.03), and improving the stool consistency (type 6 at the Bristol Stool chart instead of type 5) in those at term (p < 0.0001). Moreover, a significant reduction (8.65 vs. 7.98 LogCFU/g of feces, p < 0.03) of B. fragilis in the bottle-fed group receiving the probiotic formulation was observed. Frontiers Media S.A. 2018-05-25 /pmc/articles/PMC5980983/ /pubmed/29888226 http://dx.doi.org/10.3389/fnut.2018.00039 Text en Copyright © 2018 Aloisio, Prodam, Giglione, Bozzi Cionci, Solito, Bellone, Baffoni, Mogna, Pane, Bona and Di Gioia. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Nutrition
Aloisio, Irene
Prodam, Flavia
Giglione, Enza
Bozzi Cionci, Nicole
Solito, Arianna
Bellone, Simonetta
Baffoni, Loredana
Mogna, Luca
Pane, Marco
Bona, Gianni
Di Gioia, Diana
Three-Month Feeding Integration With Bifidobacterium Strains Prevents Gastrointestinal Symptoms in Healthy Newborns
title Three-Month Feeding Integration With Bifidobacterium Strains Prevents Gastrointestinal Symptoms in Healthy Newborns
title_full Three-Month Feeding Integration With Bifidobacterium Strains Prevents Gastrointestinal Symptoms in Healthy Newborns
title_fullStr Three-Month Feeding Integration With Bifidobacterium Strains Prevents Gastrointestinal Symptoms in Healthy Newborns
title_full_unstemmed Three-Month Feeding Integration With Bifidobacterium Strains Prevents Gastrointestinal Symptoms in Healthy Newborns
title_short Three-Month Feeding Integration With Bifidobacterium Strains Prevents Gastrointestinal Symptoms in Healthy Newborns
title_sort three-month feeding integration with bifidobacterium strains prevents gastrointestinal symptoms in healthy newborns
topic Nutrition
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5980983/
https://www.ncbi.nlm.nih.gov/pubmed/29888226
http://dx.doi.org/10.3389/fnut.2018.00039
work_keys_str_mv AT aloisioirene threemonthfeedingintegrationwithbifidobacteriumstrainspreventsgastrointestinalsymptomsinhealthynewborns
AT prodamflavia threemonthfeedingintegrationwithbifidobacteriumstrainspreventsgastrointestinalsymptomsinhealthynewborns
AT giglioneenza threemonthfeedingintegrationwithbifidobacteriumstrainspreventsgastrointestinalsymptomsinhealthynewborns
AT bozzicioncinicole threemonthfeedingintegrationwithbifidobacteriumstrainspreventsgastrointestinalsymptomsinhealthynewborns
AT solitoarianna threemonthfeedingintegrationwithbifidobacteriumstrainspreventsgastrointestinalsymptomsinhealthynewborns
AT bellonesimonetta threemonthfeedingintegrationwithbifidobacteriumstrainspreventsgastrointestinalsymptomsinhealthynewborns
AT baffoniloredana threemonthfeedingintegrationwithbifidobacteriumstrainspreventsgastrointestinalsymptomsinhealthynewborns
AT mognaluca threemonthfeedingintegrationwithbifidobacteriumstrainspreventsgastrointestinalsymptomsinhealthynewborns
AT panemarco threemonthfeedingintegrationwithbifidobacteriumstrainspreventsgastrointestinalsymptomsinhealthynewborns
AT bonagianni threemonthfeedingintegrationwithbifidobacteriumstrainspreventsgastrointestinalsymptomsinhealthynewborns
AT digioiadiana threemonthfeedingintegrationwithbifidobacteriumstrainspreventsgastrointestinalsymptomsinhealthynewborns